Ed DeVaney named President of CVS Caremark


Werte in diesem Artikel
Aktien

80.06 EUR 0.46 EUR 0.58 %

WOONSOCKET, R.I., Feb. 17, 2025 /PRNewswire/ -- Today, CVS Health® (NYSE: CVS) named Ed DeVaney president of the company's CVS Caremark pharmacy benefit management business. He was named interim president in December 2024. DeVaney will report to Prem Shah, group president, CVS Health.

CVS Health (PRNewsFoto/CVS Health)

"Ed's ability to build and grow a strong team culture, while prioritizing talent development, leads to strong business results," said CVS Health president and CEO, David Joyner. "His commitment shows every day in his deep understanding of our industry, his advocacy for our business, and a proven track record of anticipating and solving client needs."

"I am honored to take on this role and to work with our dedicated colleagues who are focused on making prescription drugs more affordable and delivering better care to everyone we are privileged to serve," said DeVaney. "The role of PBMs has never been more critical in achieving affordability and access to medicine in our country, and our to drive greater drug pricing transparency through innovation has never been more needed."

DeVaney joined CVS Health in 2005, growing his career across CVS Caremark and Aetna, most recently leading CVS Caremark sales and account management as president, Employer & Health Plans, where he was responsible for growing and retaining our customer base across the PBM's lines of business, including government services and coalitions. He also was responsible for our PBM Marketing team. Before joining CVS Health, Ed managed client relationships at Hewitt Associates, focusing on health care consulting and benefits administration.

About CVS Health
CVS Health® is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated colleagues – including more than 40,000 physicians, pharmacists, nurses and nurse practitioners. Wherever and whenever people need us, we help them with their health – whether that's managing chronic diseases, staying compliant with their medications or accessing affordable health and wellness services in the most convenient ways. We help people navigate the health care system – and their personal health care – by improving access, lowering costs and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day. Follow @CVSHealth on social media.

Media contact
Ethan Slavin
860-273-6095
Ethan.Slavin@CVSHealth.com

Investor contact
Larry McGrath
800-201-0938
InvestorInfo@CVSHealth.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ed-devaney-named-president-of-cvs-caremark-302378025.html

SOURCE CVS Health

Aktuelle CVS Health Aktie News

Werbung

CVS Health Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für CVS Health nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
05.06.19 CVS Health Buy Standpoint Research
15.04.19 CVS Health Perform Oppenheimer & Co. Inc.
12.04.19 CVS Health Market Perform BMO Capital Markets
18.12.18 CVS Health Overweight Barclays Capital
26.10.18 CVS Health Peer Perform Wolfe Research

Information


Die Handels- und Depotfunktionen in diesem Broker Cockpit werden für Finanzinstrumente von der Finanzen.net Zero GmbH als vertraglich gebundener Vermittler der DonauCapital Wertpapier GmbH (§ 3 Abs. 2 WpIG) bereitgestellt; bei Kryptowerten werden die Handels- und Depotfunktionen in diesem Broker Cockpit ausschließlich von der DonauCapital Wertpapier GmbH bereitgestellt. Die Finanzen.net GmbH stellt ausschließlich den technischen Rahmen bereit und ist in die Wertpapier- und Kryptodienstleistung nicht einbezogen.